시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 혈류동태 보정 기기 시장 보고서(2025년)
Hemodynamic Flow Alteration Devices Global Market Report 2025
상품코드 : 1717033
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,319,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,134,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,949,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

혈류동태 보정 기기 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 7.9%의 연평균 복합 성장률(CAGR)로 12억 1,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 신경혈관 질환의 유병률 증가, 최소 침습 뇌수술에 대한 수요 증가, 노인 환자 증가, 혈전 사건 위험 증가, 가처분 소득 증가 등의 요인에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 최소침습 수술의 채택, 생체 적합성 재료의 발전, 웨어러블 모니터링 시스템의 개발, 인공지능과 머신러닝의 통합, 이러한 장비와 심장 모니터링 시스템의 통합 등이 있습니다.

심혈관 질환의 유병률 증가는 혈류동태 보정 기기 시장의 성장을 가속할 것으로 예측됩니다. 심혈관 질환(CVD)은 심장과 혈관에 영향을 미치는 다양한 질환을 포함하며, CVD 환자 증가는 주로 고령화, 건강에 해로운 식습관, 좌식 생활습관, 고혈압 및 당뇨병과 같은 질환 증가율 등의 요인에 기인합니다. 혈류동태 보정 기기는 심부전, 고혈압, 동맥폐색 등 심혈관계 질환 환자의 혈류를 관리하는 데 매우 중요합니다. 예를 들어, 영국에 기반을 둔 심혈관 연구 자선단체인 영국심장재단(British Heart Foundation)의 보고에 따르면, 영국에서 약 760만 명이 심장 및 순환기 질환을 앓고 있으며, 그 중 남성 400만 명, 여성 360만 명이 앓고 있습니다. 100만 명 증가하고, 2040년까지 200만 명이 더 늘어날 것으로 예측되고 있습니다. 이처럼 심혈관 질환의 유병률 증가는 혈류동태 보정 기기 시장의 중요한 촉진요인이 되고 있습니다.

혈류동태 보정 기기 시장의 주요 기업들은 더 나은 심장 보조를 제공하고, 환자의 예후를 개선하며, 전 세계적으로 증가하는 심부전 발생률을 해결하기 위해 좌심실 보조 순환 장치(LVAD)와 같은 첨단 솔루션 개발에 주력하고 있습니다. 심장을 보조하는 기계식 펌프입니다. 예를 들어, 2022년 1월 인도 정부 산하 연구기관인 인도공과대학 칸푸르는 Hridyantra라는 이니셔티브를 시작했습니다. 이 프로젝트는 말기 심부전 환자의 요구에 부응하는 최첨단 LVAD를 개발하는 것을 목표로 하고 있습니다. 이 장치는 심장 이식을 위한 가교 역할을 하거나, 이식 후보에 오르지 못한 환자들에게 장기적인 해결책을 제공하는 것을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Hemodynamic flow alteration devices are medical instruments designed to modify the dynamics of blood flow within the circulatory system. These devices are often utilized in procedures such as vascular surgery or heart condition treatments. They can influence factors such as the speed, direction, or resistance of blood flow to enhance circulation or reduce strain on vital organs.

The primary types of hemodynamic flow alteration devices include embolic protection devices and chronic total occlusion devices. An embolic protection device is specifically designed to capture and remove embolic material that may become dislodged during procedures such as angioplasty. This prevents the material from traveling to vital organs and causing blockages. These devices are used in various applications, including cardiovascular diseases, neurological disorders, renal conditions, and respiratory disorders, and are employed by several end users, including hospitals, clinics, ambulatory care centers, home care settings, and more.

The hemodynamic flow alteration devices market research report is one of a series of new reports from The Business Research Company that provides hemodynamic flow alteration devices market statistics, including the hemodynamic flow alteration devices industry global market size, regional shares, competitors with the hemodynamic flow alteration devices market share, detailed hemodynamic flow alteration devices market segments, market trends, and opportunities, and any further data you may need to thrive in the hemodynamic flow alteration devices industry. This hemodynamic flow alteration devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hemodynamic flow alteration devices market size has grown strongly in recent years. It will grow from $0.82 billion in 2024 to $0.89 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth during the historic period can be attributed to factors such as the expanding aging population, increased healthcare expenditure, a rise in the prevalence of cardiovascular diseases, growing risk factors such as obesity, diabetes, and hypertension, and increased investment in research and development.

The hemodynamic flow alteration devices market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of neurovascular diseases, a growing demand for minimally invasive neurosurgery, a rise in geriatric patients, an increased risk of thrombotic events, and rising disposable incomes. Key trends in the forecast period include the adoption of minimally invasive procedures, advancements in biocompatible materials, the development of wearable monitoring systems, the integration of artificial intelligence and machine learning, and the incorporation of these devices with cardiac monitoring systems.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the hemodynamic flow alteration devices market. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The rise in CVD cases is primarily attributed to factors such as aging populations, unhealthy diets, sedentary lifestyles, and increasing rates of conditions such as hypertension and diabetes. Hemodynamic flow alteration devices are crucial for managing blood flow in patients with cardiovascular conditions such as heart failure, hypertension, and arterial blockages. For example, a report by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are living with heart and circulatory diseases, with 4 million men and 3.6 million women affected. By 2030, this number is projected to increase by 1 million, and by 2040, it could rise by an additional 2 million. Thus, the growing prevalence of cardiovascular diseases is a key driver for the hemodynamic flow alteration devices market.

Leading companies in the hemodynamic flow alteration devices market are focusing on the development of advanced solutions such as left ventricular assist devices (LVADs) to provide better cardiac support, improve patient outcomes, and tackle the rising incidence of heart failure worldwide. An LVAD is a mechanical pump implanted in patients with severe heart failure to assist the heart in pumping blood. For example, in January 2022, the Indian Institute of Technology-Kanpur, a government research institute based in India, launched an initiative called Hridyantra. This project aims to develop a cutting-edge LVAD to meet the needs of patients with end-stage heart failure. The device is intended to either serve as a bridge to a heart transplant or provide a long-term solution for those who are not candidates for a transplant.

In October 2024, Johnson & Johnson, a pharmaceutical company based in the US, acquired V-Wave Inc. for an undisclosed sum. This acquisition is intended to bolster Johnson & Johnson's position in the cardiovascular disease sector by adding V-Wave's groundbreaking Ventura interatrial shunt to its MedTech portfolio. V-Wave Inc., a US-based company, specializes in the development of hemodynamic flow alteration devices.

Major players in the hemodynamic flow alteration devices market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Getinge AB, Lepu Medical Technology (Beijing) Co. Ltd., Abiomed Inc., LivaNova PLC, Cordis US Corp., Silk Road Medical Inc., Berlin Heart GmbH, CorWave SA, Jarvik Heart Inc., and CARMAT SA.

North America was the largest region in the hemodynamic flow alteration devices market in 2024. The regions covered in hemodynamic flow alteration devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hemodynamic flow alteration devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemodynamic flow alteration devices market consists of sales of flow diverters, vascular stents, blood flow regulators, and monitoring tools. Values in and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemodynamic Flow Alteration Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemodynamic flow alteration devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hemodynamic flow alteration devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemodynamic flow alteration devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Hemodynamic Flow Alteration Devices Market Characteristics

3. Hemodynamic Flow Alteration Devices Market Trends And Strategies

4. Hemodynamic Flow Alteration Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hemodynamic Flow Alteration Devices Growth Analysis And Strategic Analysis Framework

6. Hemodynamic Flow Alteration Devices Market Segmentation

7. Hemodynamic Flow Alteration Devices Market Regional And Country Analysis

8. Asia-Pacific Hemodynamic Flow Alteration Devices Market

9. China Hemodynamic Flow Alteration Devices Market

10. India Hemodynamic Flow Alteration Devices Market

11. Japan Hemodynamic Flow Alteration Devices Market

12. Australia Hemodynamic Flow Alteration Devices Market

13. Indonesia Hemodynamic Flow Alteration Devices Market

14. South Korea Hemodynamic Flow Alteration Devices Market

15. Western Europe Hemodynamic Flow Alteration Devices Market

16. UK Hemodynamic Flow Alteration Devices Market

17. Germany Hemodynamic Flow Alteration Devices Market

18. France Hemodynamic Flow Alteration Devices Market

19. Italy Hemodynamic Flow Alteration Devices Market

20. Spain Hemodynamic Flow Alteration Devices Market

21. Eastern Europe Hemodynamic Flow Alteration Devices Market

22. Russia Hemodynamic Flow Alteration Devices Market

23. North America Hemodynamic Flow Alteration Devices Market

24. USA Hemodynamic Flow Alteration Devices Market

25. Canada Hemodynamic Flow Alteration Devices Market

26. South America Hemodynamic Flow Alteration Devices Market

27. Brazil Hemodynamic Flow Alteration Devices Market

28. Middle East Hemodynamic Flow Alteration Devices Market

29. Africa Hemodynamic Flow Alteration Devices Market

30. Hemodynamic Flow Alteration Devices Market Competitive Landscape And Company Profiles

31. Hemodynamic Flow Alteration Devices Market Other Major And Innovative Companies

32. Global Hemodynamic Flow Alteration Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemodynamic Flow Alteration Devices Market

34. Recent Developments In The Hemodynamic Flow Alteration Devices Market

35. Hemodynamic Flow Alteration Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기